Vasculitis: do we know more to classify better?

被引：0
|
作者：
Ezgi Deniz Batu
Seza Ozen
机构：
[1] Hacettepe University Faculty of Medicine,Division of Paediatric Rheumatology, Department of Paediatrics
来源：
Pediatric Nephrology | 2015年 / 30卷
关键词：
Systemic vasculitis; Classification criteria; Nomenclature; ANCA-associated vasculitis; Chapel Hill Consensus Conference;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The systemic vasculitides are a heterogeneous group of disorders characterized by the inflammation of blood vessels. The development and implementation of advanced diagnostic tests and genetic studies have resulted in substantial improvement in our understanding of vasculitis pathogenesis, resulting in the revision of the nomenclature and classification for vasculitis. Multicenter, collaborative studies are currently underway to develop improved diagnostic criteria. In this review, the major nomenclature and classification systems for vasculitides are summarized, with special emphasis on those emerging from the recent 2012 Chapel Hill Consensus Conference (CHCC).
引用
收藏
页码：1425 / 1432
页数：7
相关论文
共 50 条
  • [1] Vasculitis: do we know more to classify better?
    Batu, Ezgi Deniz
    Ozen, Seza
    PEDIATRIC NEPHROLOGY, 2015, 30 (09) : 1425 - 1432
  • [2] Commentary: Attacks on royalty - The more we know, the more we can classify
    Glancy, Graham D.
    JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW, 2008, 36 (01): : 68 - 73
  • [3] Better to do with what we know
    Jacques, Jean-Paul
    ACTA ENDOSCOPICA, 2007, 37 (05) : 692 - 692
  • [4] Methoxyflurane is a better painkiller than placebo: but do we want to know more?
    Carley, Simon
    Body, Richard
    EMERGENCY MEDICINE JOURNAL, 2014, 31 (08) : 610 - 610
  • [5] Perspective: We need to know better to do better
    Esserman, Laura
    NATURE, 2020, 579 (7800) : S5 - S5
  • [6] Atrial Fibrillation in Transition: Do we know more today than we do not know?
    Eckardt, Lars
    Perings, Christian
    AKTUELLE KARDIOLOGIE, 2021, 10 (03) : 159 - 160
  • [7] MELAS - HOW MUCH DO WE KNOW AND SHOULD WE KNOW MORE?
    Mannali, V.
    Moran, K.
    Thomas, I. M.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [8] Malignant Melanoma in People Living with HIV/AIDS: Can We Know More, Can We Do Better?
    Trunfio, Mattia
    Ribero, Simone
    Bonora, Stefano
    Di Perri, Giovanni
    Quaglino, Pietro
    Andrea, Calcagno
    AIDS REVIEWS, 2019, 21 (02) : 65 - 75
  • [9] Schizophrenia today: do we know any more and can we treat it better than a decade ago?
    DeLisi, Lynn E.
    Fleischhacker, W. Wolfgang
    CURRENT OPINION IN PSYCHIATRY, 2008, 21 (02) : 131 - 132
  • [10] What Do We Know About Malignancies in IgA Vasculitis?
    Hocevar, Alojzija
    Ostrovrsnik, Jaka
    Jurcic, Vesna
    Rotar, Ziga
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 5126 - 5127
12345